These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26820992)

  • 1. Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers.
    Tumiati M; Munne PM; Edgren H; Eldfors S; Hemmes A; Kuznetsov SG
    Oncogene; 2016 Sep; 35(35):4601-10. PubMed ID: 26820992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53-mutant mice.
    Tumiati M; Hemmes A; Uusivirta S; Koopal S; Kankainen M; Lehtonen E; Kuznetsov SG
    J Pathol; 2015 Jan; 235(1):136-46. PubMed ID: 25270124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
    Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice.
    Kuznetsov SG; Haines DC; Martin BK; Sharan SK
    Cancer Res; 2009 Feb; 69(3):863-72. PubMed ID: 19155299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
    Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
    JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
    Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12111-6. PubMed ID: 17626182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours.
    Francis JC; Melchor L; Campbell J; Kendrick H; Wei W; Armisen-Garrido J; Assiotis I; Chen L; Kozarewa I; Fenwick K; Swain A; Smalley MJ; Lord CJ; Ashworth A
    J Pathol; 2015 Jun; 236(2):186-200. PubMed ID: 25692405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
    Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
    Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair.
    Bassi C; Li YT; Khu K; Mateo F; Baniasadi PS; Elia A; Mason J; Stambolic V; Pujana MA; Mak TW; Gorrini C
    Cell Death Differ; 2016 Jul; 23(7):1198-208. PubMed ID: 26915295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
    Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
    Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer.
    Li N; McInerny S; Zethoven M; Cheasley D; Lim BWX; Rowley SM; Devereux L; Grewal N; Ahmadloo S; Byrne D; Lee JEA; Li J; Fox SB; John T; Antill Y; Gorringe KL; James PA; Campbell IG
    J Natl Cancer Inst; 2019 Dec; 111(12):1332-1338. PubMed ID: 30949688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.
    Zhang Y; Xiong S; Liu B; Pant V; Celii F; Chau G; Elizondo-Fraire AC; Yang P; You MJ; El-Naggar AK; Navin NE; Lozano G
    Nat Commun; 2018 Sep; 9(1):3953. PubMed ID: 30262850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and Characterization of a Brca1
    Hámori L; Kudlik G; Szebényi K; Kucsma N; Szeder B; Póti Á; Uher F; Várady G; Szüts D; Tóvári J; Füredi A; Szakács G
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic structural rearrangements in genetically engineered mouse mammary tumors.
    Varela I; Klijn C; Stephens PJ; Mudie LJ; Stebbings L; Galappaththige D; van der Gulden H; Schut E; Klarenbeek S; Campbell PJ; Wessels LF; Stratton MR; Jonkers J; Futreal PA; Adams DJ
    Genome Biol; 2010; 11(10):R100. PubMed ID: 20942901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous recombination-deficient mutation cluster in tumor suppressor
    Prakash R; Rawal Y; Sullivan MR; Grundy MK; Bret H; Mihalevic MJ; Rein HL; Baird JM; Darrah K; Zhang F; Wang R; Traina TA; Radke MR; Kaufmann SH; Swisher EM; Guérois R; Modesti M; Sung P; Jasin M; Bernstein KA
    Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2202727119. PubMed ID: 36099300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous homologous recombination is decreased in Rad51C-deficient hamster cells.
    Drexler GA; Rogge S; Beisker W; Eckardt-Schupp F; Zdzienicka MZ; Fritz E
    DNA Repair (Amst); 2004 Oct; 3(10):1335-43. PubMed ID: 15336628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.
    Smolen GA; Muir B; Mohapatra G; Barmettler A; Kim WJ; Rivera MN; Haserlat SM; Okimoto RA; Kwak E; Dahiya S; Garber JE; Bell DW; Sgroi DC; Chin L; Deng CX; Haber DA
    Cancer Res; 2006 Apr; 66(7):3452-5. PubMed ID: 16585167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator.
    McDaniel JM; Morrissey RL; Dibra D; Patel LR; Xiong S; Zhang Y; Chau GP; Su X; Qi Y; El-Naggar AK; Lozano G
    Cancer Res Commun; 2024 Aug; 4(8):1991-2007. PubMed ID: 38994678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.